Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology - Dr. Sam Mbulaiteye

Sam M. Mbulaiteye, MBChB, M.Phil., M.Med., of the DCEG Infections and Immunoepidemiology Branch (IIB), presented an NIH Director's Seminar titled "Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology", and discussed his ideas for future research collaboration.

Read Dr. Mbulaiteye's article "Burkitt lymphoma studies may also advance research on other cancers, HIV, malaria" in the NIH Fogarty Global Health Matters newsletter.

Learn more about Epidemiology of Burkitt Lymphoma in East-African Children and Minors (EMBLEM), a multicountry and multiyear case-control study of childhood Burkitt's lymphoma in Uganda, Tanzania and Kenya conducted by NCI.

Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology - Dr. Sam Mbulaiteye

Sam M. Mbulaiteye, MBChB, M.Phil., M.Med., of the DCEG Infections and Immunoepidemiology Branch (IIB), presented an NIH Director's Seminar titled "Burkitt Lymphoma: A Model of Polymicrobial Carcinogenesis and Global Oncology", and discussed his ideas for future research collaboration.

Email